NCT02714699

Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy

Randomized Clinical Trial of Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium in Reducing Pain During Office Hysteroscopy

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 129 (actual)
• Sponsor: Assiut University · Academic / Other
• Sex: Female
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The study aims to determine the efficacy of oral hyoscine butyl bromide versus diclofenac potassium on the pain scores during office hysteroscopy

Conditions

• Endoscopy

Interventions

Type	Name	Description
DRUG	diclofenac potassium	patients will take oral diclofenac potassium; two tablets (cataflam 25 mg) and one tablet placebo one hour before the procedure
DRUG	hyoscine butyl bromide	patients will take oral hyoscine-N- butyl bromide; 2 tablets (buscopan 10 mg) one hour before the procedure
DRUG	placebo	patients will take oral placebo; 2 tablets one hour before the procedure

Timeline

• Start date: 2016-10-01
• Primary completion: 2017-03-01
• Completion: 2017-05-01
• First posted: 2016-03-21
• Last updated: 2018-01-05

Locations

1 site across 1 country: Egypt